Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial.
Saved in:
| Title: | Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial. |
|---|---|
| Authors: | Perroud A; Global Clinical Development Strategy, Sanofi, São Paulo, Brazil., Madruga JVR; Centro de Referência e Treinamento DST/AIDS, São Paulo, Brazil., Fernandes L; Aids and Molecular Immunology Laboratory, Hospital Geral de Nova Iguaçu & IOC/Fiocruz, Rio de Janeiro, Brazil., Luz K; Instituto de Medicina Tropical da Universidade Federal do Rio Grande do Norte, Natal, Brazil., Lukic N; IQVIA (on behalf of Sanofi), Belgrade, Serbia., Bourée S; IVIDATA Life Sciences (on behalf of Sanofi), Lyon, France., Sanchez-Ruiz M; Global Clinical Study Management, Sanofi, Ciudad de Mexico, Mexico., Pegoraro F; Global Clinical Study Management, Sanofi, São Paulo, Brazil., Petit C; Global Immunology, Sanofi, Marcy-l'Étoile, France., Zambrano B; Global Clinical Development Strategy, Sanofi, Montevideo, Uruguay., Dayan G; Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2582237. Date of Electronic Publication: 2025 Nov 10. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2025.2582237 |
